Stocks News

Bristol-Myers Squibb stock is a speculative buy (Technical Analysis) (NYSE:BMY)

Silhouette form of bull on technology financial graph 3d illustration

you

Bristol-Myers Squibb, Inc.New York Stock Exchange: BMY) is engaged in the healthcare sector and pharmaceutical industry. Although not a factor in the company’s analysis, BMY is expected to have annual revenue of $45.85 billion and annual earnings per share in 2024.

Related Articles

Back to top button